Edition:
United States

Celldex Therapeutics Inc (CLDX.OQ)

CLDX.OQ on NASDAQ Stock Exchange Capital Market

0.34USD
18 Jan 2019
Change (% chg)

$0.05 (+18.21%)
Prev Close
$0.29
Open
$0.30
Day's High
$0.37
Day's Low
$0.29
Volume
3,007,574
Avg. Vol
373,242
52-wk High
$2.89
52-wk Low
$0.18

Chart for

About

Celldex Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of several immunotherapy technologies for the treatment of cancer and other diseases. Its lead drug Rintega (also referred to as rindopepimut and CDX-110) is a therapeutic vaccine, which is meant for the... (more)

Overall

Beta: 2.67
Market Cap(Mil.): $405.56
Shares Outstanding(Mil.): 128.34
Dividend: --
Yield (%): --

Financials

  CLDX.OQ Industry Sector
P/E (TTM): -- 69.71 33.71
EPS (TTM): -1.10 -- --
ROI: -43.88 8.99 14.48
ROE: -53.51 10.13 15.99

BRIEF-Novartis Receives Health Canada Approval Of Its Car-T Cell Therapy, Kymriah I

* NOVARTIS RECEIVES HEALTH CANADA APPROVAL OF ITS CAR-T CELL THERAPY, KYMRIAH™ (TISAGENLECLEUCEL)I

Sep 06 2018

Earnings vs. Estimates